Navigation Links
Twelfth annual Wiley Prize in Biomedical Sciences awarded
Date:1/31/2013

Hoboken, N.J. -- January 31, 2013 -- Deborah E. Wiley, Chair of The Wiley Foundation, John Wiley & Sons, Inc. (NYSE: JWa & JWb), announced today that the twelfth annual Wiley Prize in Biomedical Sciences will be awarded to Dr. Michael Young, Rockefeller University, Dr. Jeffrey Hall, Brandeis University (Emeritus), and Dr. Michael Rosbash, Brandeis University.

The Wiley Prize is being awarded to Dr. Young, Dr. Hall and Dr. Rosbash for the discovery of the molecular mechanisms governing circadian rhythms.

"The molecular network discovered by these researchers imparts cyclic behavior to many biological processes including sleep and wakefulness, metabolism and even the response to drugs," said Dr. Gnter Blobel, Chairman of the awards jury for the Wiley Prize.

Studies of the molecular basis for circadian rhythmicity began in the early 1980s in the laboratory of Dr. Young at Rockefeller University and Drs. Hall and Rosbash at Brandeis. Over the past three decades the work of the three investigators focused on the fruitfly Drosophila melanogaster. Their research has shown that the fly's circadian clocks are formed through the actions of a small group of genes.

These discoveries apply not only to insects but also to humans and other mammals, and they could ultimately lead to the development of drugs to treat sleep disorders and related ones such as jet lag, plus maladies associated with shift-work.

The Wiley Prize in Biomedical Sciences recognizes contributions that have opened new fields of research or have advanced novel concepts or their applications in a particular biomedical discipline. It honors a specific contribution or a series of contributions that demonstrate significant leadership and innovation. This year's award will be presented to Dr. Rosbash, Dr. Hall and Dr. Young on April 5, 2013 at The Rockefeller University in New York City.

Dr. Blobel, a John D. Rockefeller, Jr. Professor of Cell Biology at The Rockefeller University, was awarded the Nobel Prize for Physiology or Medicine in 1999. The Wiley Prize awards jury also includes Dr. Qais Al-Awqati, a physiologist at Columbia University's College of Physicians and Surgeons; Dr. David J. Anderson, a developmental neurobiologist at the California Institute of Technology; Dr. Joan A. Steitz, a molecular biologist at Yale University; and Dr. H. Robert Horvitz, a biologist at MIT and recipient of the 2002 Nobel Prize for Physiology or Medicine.

Last year's Wiley Prize recipients were Dr. Michael Sheetz, Dr. James Spudich, and Dr. Ronald Vale for explaining how cargo is moved by molecular motors along two different systems of tracks within cells. The three researchers also received the 2012 Albert Lasker Basic Medical Research Award for their discoveries concerning cytoskeletal motor proteins.

Among the many distinguished past recipients of the Wiley Prize in Biomedical Sciences, five have also been awarded the Nobel Prize for Physiology or Medicine. Dr. Elizabeth Blackburn and Dr. Carol Greider, recipients of the Wiley Prize in Biomedical Sciences in 2006, received the 2009 Nobel Prize in Physiology or Medicine for the discovery of how chromosomes are protected by telomeres and the enzyme telomerase. Dr. Andrew Z. Fire and Dr. Craig C. Mello, co-recipients of the Wiley Prize in 2003, received the 2006 Nobel Prize for Physiology or Medicine for their discovery of RNA interferencegene silencing by double-stranded RNA. Dr. H. Robert Horvitz, a co-recipient of the first Wiley Prize in 2002, shared the 2002 Nobel Prize for Physiology or Medicine for his respective work on how genes regulate organ development and cell death.


'/>"/>
Contact: Peter Peretzman
Sciencenewsroom@wiley.com
201-748-6098
Wiley
Source:Eurekalert

Related medicine news :

1. Omnipress to Exhibit at the Alliance for Continuing Education in the Health Professions’ Annual Conference
2. Is COBRA Right for You and Worth the $15,000 Annual Price Tag?
3. The Nurse Practitioner marks 25th Annual Legislative Update
4. Announcing the Release of the Michigan Lupus Foundation 2012 Annual Report
5. Generic HIV treatment strategy could save nearly $1 billion annually but may be less effective
6. Dr. Goldberg to Co-Organize 15th Annual IMCAS Meeting in Paris
7. Tickets Now on Sale for Sid Jacobson JCC's Annual Auction
8. Avenidas Village Hosts Second Annual Financial Conference
9. AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at American Association for Hand Surgery 2013 Annual Meeting
10. AxoGen, Inc. to sponsor Educational Symposium and Panel Discussion at 2013 Annual Meetings of American Association for Hand Surgery, American Society for Peripheral Nerve, and American Society for Reconstructive Microsurgery
11. Daytop New Jersey Launches Annual Holiday Appeal to Raise Money for Disaster Preparedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s most liveable ... Unit’s (EIU) annual Liveability Index. , The Index surveys 140 of the world’s cities ... 2006, Melbourne has consistently come in the top three of the index. So what ...
(Date:8/16/2017)... ... August 16, 2017 , ... Connexion Point, a technology-enabled healthcare services company ... fourth consecutive year. With 197% revenue growth over the past three years, ... growing companies. , Previous honors include ranking 86th on the Inc. 500 ...
(Date:8/16/2017)... Rochester, Michigan (PRWEB) , ... August 16, 2017 ... ... treatment options to patients suffering from chronic pelvic pain. In addition to ... various pelvic pain disorders including endometriosis, menorrhagia (abnormal heavy bleeding during menstruation), uterine ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... an annual all-encompassing awards program which recognizes organizations that demonstrate the core values ... of comprehensive award categories. , “As a global company, we are expanding our ...
(Date:8/16/2017)... ... ... “Mom, God's Got This: Jamie's Story” is the creation of published author, Karen F. Norton, ... insatiable appetite for God’s Word. , “I froze between the half walls, shelves on my ... oatmeal. I have one to this day on proud display in my dining room hutch; ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
(Date:7/28/2017)... 2017 EnvoyHealth, a Diplomat company, has partnered with ... CleverCap LITE, a technology designed to improve patient medication ... health technology solutions and services that help track and ... CleverCap LITE offers medication monitoring and control for ... Records date and time ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: